Development of a new DNA vaccine based on mycobacterial ESAT-6 antigen delivered by recombinant invasive Lactococcus lactis FnBPA+
- 609 Downloads
The use of the food-grade bacterium Lactococcus lactis as a vehicle for the oral delivery of DNA vaccine plasmids constitutes a promising strategy for vaccination. The delivery of DNA plasmids into eukaryotic cells is of critical importance for subsequent DNA expression and effectiveness of the vaccine. In this context, the use of the recombinant invasive L. lactis FnBPA+ (fibronectin-binding protein A) strain for the oral delivery of the eukaryotic expression vector vaccination using lactic acid bacteria (pValac), coding for the 6-kDa early secreted antigenic target (ESAT-6) gene of Mycobacterium tuberculosis, could represent a new DNA vaccine strategy against tuberculosis. To this end, the ESAT-6 sequence was cloned into the pValac vector; the L. lactis fibronectin-binding protein A (FnBPA)+ (pValac:ESAT-6) strain was obtained, and its immunological profile was checked in BALB/c mice. This strain was able to significantly increase interferon gamma (IFN-γ) production in spleen cells, showing a systemic T helper 1 (Th1) cell response. The mice also showed a significant increase in specific secretory immunoglobulin A (sIgA) production in colon tissue and fecal extracts. Thus, this is the first time that L. lactis has been used to deliver a plasmid DNA harboring a gene that encodes an antigen against tuberculosis through mucous membranes.
KeywordsLactococcus lactis DNA delivery system Intestinal mucosa Tuberculosis ESAT-6
This study was supported by the grants from the Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq), Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES), and Fundação de Amparo à Pesquisa do estado de Minas Gerais (Fapemig). We would like to thank Msc. Alberto Fernandes de Oliveira Júnior for Fig. 6.
Conflict of interest
The authors declare that they have no conflict of interest.
- Cervantes-Villagrana AR, Hernández-Pando R, Biragyn A, Castañeda-Delgado J, Bodogai M, Martínez-Fierro M, Sada E, Trujillo V, Enciso-Moreno A, Rivas-Santiago B (2013) Prime-boost BCG vaccination with DNA vaccines based in β-defensin-2 and mycobacterial antigens ESAT6 or Ag85B improve protection in a tuberculosis experimental model. Vaccine 31(4):676–684. doi: 10.1016/j.vaccine.2012.11.042 PubMedCrossRefGoogle Scholar
- Del Carmen S, Zurita-Turk M, Lima FA, dos Santos JSC, Leclecq SY, Chatel JM, Azevedo V, Leblanc AM, Miyoshi A, Leblanc JG (2013) A novel interleukin-10 DNA mucosal delivery system attenuates intestinal inflammation in a mouse model. Eur J Inflamm 11(3):25–38Google Scholar
- Green MR, Sambrook J (2012) Molecular cloning: a laboratory manual 4th ed. Cold Spring Harbor, New YorkGoogle Scholar
- Innocentin S, Guimarães V, Myoshi A, Azevedo V, Langella P, Chatel JM, Lefèvre F (2009) Lactococcus lactis expressing either Staphylococcus aureus fibronectin-binding protein A or Listeria monocytogenes internalin A can efficiently internalize and deliver DNA in human epithelial cells. Appl Environ Microbiol 75(14):4870–4878. doi: 10.1128/AEM. 00825-09 PubMedCentralPubMedCrossRefGoogle Scholar
- Lu J, Wang C, Zhou Z, Zhang Y, Cao T, Shi C, Chen Z, Chen L, Cai C, Fan X (2011) Immunogenicity and protective efficacy against murine tuberculosis of a prime-boost regimen with BCG and a DNA vaccine expressing ESAT-6 and Ag85A fusion protein. Clin Dev Immunol 2011:617892. doi: 10.1155/2011/617892 PubMedCentralPubMedCrossRefGoogle Scholar
- Mustafa AS, Shaban FA, Al-Attiyah R, Abal AT, El-Shamy AM, Andersen P, Oftung F (2003) Human Th1 cell lines recognize the Mycobacterium tuberculosis ESAT-6 antigen and its peptides in association with frequently expressed HLA class II molecules. Scand J Immunol 57(2):125–134PubMedCrossRefGoogle Scholar
- Pontes D, Innocentin S, Del Carmen S, Almeida JF, Leblanc JG, de Moreno de Leblanc A, Blugeon S, Cherbuy C, Lefèvre F, Azevedo V, Miyoshi A, Langella P, Chatel JM (2012) Production of fibronectin binding protein a at the surface of Lactococcus lactis increases plasmid transfer in vitro and in vivo. PLoS One 7(9):e44892. doi: 10.1371/journal.pone.0044892 PubMedCentralPubMedCrossRefGoogle Scholar